Icon

Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.

Saia.trucking

News

Downgrades

Pre-Market Outlook

Markets

Analyst Ratings

Trading Ideas

ICLR

PODD

SAIA

VLRS

This Saia Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Tuesday

benzingaai2023_modern_computer_screen_with_stock_chart_stock__6576dd35-b4b0-42d8-8403-ba4e9845ab24_3

Hedge Funds

BILL

CFLT

CRMD

MSTR

NVDA

RING

WOLF

Elliott Investment Management made several portfolio moves in the fourth quarter, closing multiple options positions and shaking up the activist firm&#39;s technology exposure.

Elliott Investment Management Bets Against Nvidia In Q4 (CORRECTED)

Jim Cramer and GameStop

Equities

Large Cap

Short Sellers

Movers

BMRN

BNTX

FTAI

MRNA

NTRA

RGTI

RKLB

SNAP

Eleven large-cap stocks were the worst performers in the last week. Short positions announced for FTAI, revenue updates for MRNA, and price forecasts changed for GME, SNAP, RKLB, NTRA, LLY, ICLR, BNTX, NVO, and BMRN.

Moderna, GameStop And Snap Are Among Top Large-Cap Losers Last Week (Jan 13-Jan 17): Are The Others In Your Portfolio?

Icon PLC

Press Releases

The Gross Law Firm Reminds ICON  Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 11, 2025 - ICLR

ICON plc (ICLR) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

Legal

ICON Public Limited Company Class Action: Levi & Korsinsky Reminds ICON Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 11, 2025 – ICLR

Class Action Filed Against ICON Public Limited Company (ICLR) Seeking Recovery for Investors - Contact Levi & Korsinsky

ICLR Investors Have Opportunity to Lead ICON Public Limited Company Securities Fraud Lawsuit with the Schall Law Firm

ICON Reports First Quarter 2025 Results

ICLR Investors Have Opportunity to Lead ICON Public Limited Company Securities Fraud Lawsuit with the Schall LAW FIRM

Global ICON survey shows need for more efficient obesity clinical trial design to realise full potential of next-gen multi-indication therapies

Comments

Icon

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell